CHAMPIONS ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.21 million shares for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-04-30 was 50.50K shares, a 102.00% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-01-31 was 177.96K shares, a 26.54% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-10-31 was 101.50K shares.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-07-31 was 1.00K shares, a 98.54% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 1.21M shares, a 264.18% increase from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 330.95K shares, a 25.58% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 444.73K shares, a 138.18% increase from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 186.72K shares, a 12.45% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-04-30 | 1.21M shares 10-K · filed 2026-07-27 | |||||
| 2025-04-30 | 50.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | 228.46K shares derived: sum of 2 quarters · filed 2025-07-23 | 329.95K shares derived: sum of 3 quarters · filed 2025-07-23 | 330.95K shares 10-K · filed 2025-07-23 | ||
| 2025-01-31 | 177.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | 279.45K shares derived: sum of 2 quarters · filed 2025-03-17 | 280.45K shares 10-Q · filed 2025-03-17 | 305.45K shares derived: sum of 4 quarters · filed 2025-07-23 | ||
| 2024-10-31 | 101.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | 102.50K shares 10-Q · filed 2024-12-16 | 127.50K shares derived: sum of 3 quarters · filed 2025-07-23 | 268.13K shares derived: sum of 4 quarters · filed 2025-07-23 | ||
| 2024-07-31 | 1.00K shares 10-Q · filed 2024-09-13 | 26.00K shares derived: sum of 2 quarters · filed 2025-07-23 | 166.63K shares derived: sum of 3 quarters · filed 2025-07-23 | 166.63K shares derived: sum of 4 quarters · filed 2025-07-23 | ||
| 2024-04-30 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | 165.63K shares derived: sum of 2 quarters · filed 2025-07-23 | 165.63K shares derived: sum of 3 quarters · filed 2025-07-23 | 444.73K shares 10-K · filed 2025-07-23 | ||
| 2024-01-31 | 140.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15 | 140.63K shares derived: sum of 2 quarters · filed 2024-03-15 | 419.73K shares 10-Q · filed 2024-03-15 | 211.23K shares derived: sum of 4 quarters · filed 2024-07-19 | ||
| 2023-10-31 | 0.00 shares 10-Q · filed 2023-12-13 | 279.10K shares 10-Q · filed 2023-12-13 | 70.60K shares derived: sum of 3 quarters · filed 2024-07-19 | 174.82K shares derived: sum of 4 quarters · filed 2024-07-19 | ||
| 2023-07-31 | 68.60K shares 10-Q · filed 2023-09-13 | 70.60K shares derived: sum of 2 quarters · filed 2024-07-19 | 174.82K shares derived: sum of 3 quarters · filed 2024-07-19 | 177.32K shares derived: sum of 4 quarters · filed 2024-07-19 | ||
| 2023-04-30 | 2.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | 106.22K shares derived: sum of 2 quarters · filed 2024-07-19 | 108.72K shares derived: sum of 3 quarters · filed 2024-07-19 | 186.72K shares 10-K · filed 2024-07-19 | ||
| 2023-01-31 | 104.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | 106.72K shares derived: sum of 2 quarters · filed 2023-03-16 | 184.72K shares 10-Q · filed 2023-03-16 | 184.72K shares derived: sum of 4 quarters · filed 2023-07-24 | ||
| 2022-10-31 | 2.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | 80.50K shares 10-Q · filed 2022-12-13 | 80.50K shares derived: sum of 3 quarters · filed 2023-07-24 | 161.02K shares derived: sum of 4 quarters · filed 2023-07-24 | ||
| 2022-07-31 | 78.00K shares 10-Q · filed 2022-09-12 | 78.00K shares derived: sum of 2 quarters · filed 2023-07-24 | 158.52K shares derived: sum of 3 quarters · filed 2023-07-24 | 158.52K shares derived: sum of 4 quarters · filed 2023-07-24 | ||
| 2022-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | 80.52K shares derived: sum of 2 quarters · filed 2023-07-24 | 80.52K shares derived: sum of 3 quarters · filed 2023-07-24 | 166.05K shares 10-K · filed 2023-07-24 | ||
| 2022-01-31 | 80.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | 80.52K shares derived: sum of 2 quarters · filed 2022-03-15 | 166.05K shares 10-Q · filed 2022-03-15 | 168.05K shares derived: sum of 4 quarters · filed 2022-07-22 | ||
| 2021-10-31 | 0.00 shares 10-Q · filed 2021-12-13 | 85.53K shares 10-Q · filed 2021-12-13 | 87.53K shares derived: sum of 3 quarters · filed 2022-07-22 | 161.37K shares derived: sum of 4 quarters · filed 2022-07-22 | ||
| 2021-07-31 | 85.53K shares 10-Q · filed 2021-09-13 | 87.53K shares derived: sum of 2 quarters · filed 2022-07-22 | 161.37K shares derived: sum of 3 quarters · filed 2022-07-22 | 213.87K shares derived: sum of 4 quarters · filed 2022-07-22 | ||
| 2021-04-30 | 2.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | 75.83K shares derived: sum of 2 quarters · filed 2022-07-22 | 128.33K shares derived: sum of 3 quarters · filed 2022-07-22 | 135.83K shares 10-K · filed 2022-07-22 | ||
| 2021-01-31 | 73.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | 126.33K shares derived: sum of 2 quarters · filed 2021-03-15 | 133.83K shares 10-Q · filed 2021-03-15 | 143.83K shares derived: sum of 4 quarters · filed 2021-07-26 | ||
| 2020-10-31 | 52.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-14 | 60.00K shares 10-Q · filed 2020-12-14 | 70.00K shares derived: sum of 3 quarters · filed 2021-07-26 | 135.83K shares derived: sum of 4 quarters · filed 2021-07-26 | ||
| 2020-07-31 | 7.50K shares 10-Q · filed 2020-09-14 | 17.50K shares derived: sum of 2 quarters · filed 2021-07-26 | 83.33K shares derived: sum of 3 quarters · filed 2021-07-26 | 237.33K shares derived: sum of 4 quarters · filed 2021-07-26 | ||
| 2020-04-30 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | 75.83K shares derived: sum of 2 quarters · filed 2021-07-26 | 229.83K shares derived: sum of 3 quarters · filed 2021-07-26 | 229.83K shares 10-K · filed 2021-07-26 | ||
| 2020-01-31 | 65.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | 219.83K shares derived: sum of 2 quarters · filed 2020-03-16 | 219.83K shares 10-Q · filed 2020-03-16 | 219.83K shares derived: sum of 4 quarters · filed 2020-09-14 | ||
| 2019-10-31 | 154.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | 154.00K shares 10-Q · filed 2019-12-16 | 154.00K shares derived: sum of 3 quarters · filed 2020-09-14 | 218.83K shares derived: sum of 4 quarters · filed 2020-09-14 | ||
| 2019-07-31 | 0.00 shares 10-Q · filed 2020-09-14 | 0.00 shares derived: sum of 2 quarters · filed 2020-09-14 | 64.83K shares derived: sum of 3 quarters · filed 2020-09-14 | 205.54K shares derived: sum of 4 quarters · filed 2020-09-14 | ||
| 2019-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | 64.83K shares derived: sum of 2 quarters · filed 2020-07-28 | 205.54K shares derived: sum of 3 quarters · filed 2020-07-28 | 206.79K shares 10-K · filed 2020-07-28 | ||
| 2019-01-31 | 64.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | 205.54K shares derived: sum of 2 quarters · filed 2019-03-18 | 206.79K shares 10-Q · filed 2019-03-18 | 394.79K shares derived: sum of 4 quarters · filed 2019-07-29 | ||
| 2018-10-31 | 140.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | 141.96K shares 10-Q · filed 2018-12-17 | 329.96K shares derived: sum of 3 quarters · filed 2019-07-29 | 402.29K shares derived: sum of 4 quarters · filed 2019-07-29 | ||
| 2018-07-31 | 1.25K shares 10-Q · filed 2018-09-14 | 189.25K shares derived: sum of 2 quarters · filed 2019-07-29 | 261.58K shares derived: sum of 3 quarters · filed 2019-07-29 | 261.58K shares derived: sum of 4 quarters · filed 2019-07-29 | ||
| 2018-04-30 | 188.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | 260.33K shares derived: sum of 2 quarters · filed 2019-07-29 | 260.33K shares derived: sum of 3 quarters · filed 2019-07-29 | 455.31K shares 10-K · filed 2019-07-29 | ||
| 2018-01-31 | 72.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | 72.33K shares derived: sum of 2 quarters · filed 2018-03-19 | 267.31K shares 10-Q · filed 2018-03-19 | 267.31K shares derived: sum of 4 quarters · filed 2018-07-30 | ||
| 2017-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | 194.98K shares 10-Q · filed 2017-12-15 | 194.98K shares derived: sum of 3 quarters · filed 2018-07-30 | 294.98K shares derived: sum of 4 quarters · filed 2018-07-30 | ||
| 2017-07-31 | 194.98K shares 10-Q · filed 2017-09-14 | 194.98K shares derived: sum of 2 quarters · filed 2018-07-30 | 294.98K shares derived: sum of 3 quarters · filed 2018-07-30 | 853.33K shares derived: sum of 4 quarters · filed 2018-07-30 | ||
| 2017-04-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | 100.00K shares derived: sum of 2 quarters · filed 2018-07-30 | 658.35K shares derived: sum of 3 quarters · filed 2018-07-30 | 2.42M shares 10-K · filed 2018-07-30 | ||
| 2017-01-31 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | 658.35K shares derived: sum of 2 quarters · filed 2017-03-17 | 2.42M shares 10-Q · filed 2017-03-17 | 2.43M shares derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2016-10-31 | 558.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | 2.32M shares 10-Q · filed 2016-12-14 | 2.33M shares derived: sum of 3 quarters · filed 2017-07-28 | 2.58M shares derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2016-07-31 | 1.76M shares 10-Q · filed 2016-09-14 | 1.77M shares derived: sum of 2 quarters · filed 2017-07-28 | 2.02M shares derived: sum of 3 quarters · filed 2017-07-28 | 2.03M shares derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2016-07-21 | 1.57M shares 10-K · filed 2019-07-29 | |||||
| 2016-07-19 | 1.57M shares 10-Q · filed 2017-03-17 | |||||
| 2016-04-30 | 12.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | 254.58K shares derived: sum of 2 quarters · filed 2017-07-28 | 270.42K shares derived: sum of 3 quarters · filed 2017-07-28 | 343.75K shares 10-K · filed 2017-07-28 | ||
| 2016-01-31 | 242.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | 258.25K shares derived: sum of 2 quarters · filed 2016-03-16 | 331.58K shares 10-Q · filed 2016-03-16 | 1.00M shares derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2015-10-31 | 15.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | 89.17K shares 10-Q · filed 2015-12-15 | 759.38K shares derived: sum of 3 quarters · filed 2016-07-29 | 759.38K shares derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2015-07-31 | 73.33K shares 10-Q · filed 2015-09-11 | 743.54K shares derived: sum of 2 quarters · filed 2016-07-29 | 743.54K shares derived: sum of 3 quarters · filed 2016-07-29 | 1.62M shares derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2015-04-30 | 670.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | 670.21K shares derived: sum of 2 quarters · filed 2016-07-29 | 1.55M shares derived: sum of 3 quarters · filed 2016-07-29 | 1.76M shares 10-K · filed 2016-07-29 | 21.16M shares 10-K · filed 2015-07-29 | |
| 2015-01-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | 878.17K shares derived: sum of 2 quarters · filed 2015-03-17 | 1.09M shares 10-Q · filed 2015-03-17 | 2.04M shares derived: sum of 4 quarters · filed 2015-07-29 | ||
| 2014-10-31 | 878.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | 1.09M shares 10-Q · filed 2014-12-15 | 2.04M shares derived: sum of 3 quarters · filed 2015-07-29 | 9.24M shares derived: sum of 4 quarters · filed 2015-07-29 | ||
| 2014-07-31 | 215.00K shares 10-Q · filed 2014-09-12 | 1.16M shares derived: sum of 2 quarters · filed 2015-07-29 | 8.36M shares derived: sum of 3 quarters · filed 2015-07-29 | |||
| 2014-04-30 | 943.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | 8.15M shares derived: sum of 2 quarters · filed 2015-07-29 | 9.79M shares 10-K · filed 2015-07-29 | |||
| 2014-01-31 | 7.21M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | 8.85M shares 10-Q · filed 2014-03-14 | ||||
| 2013-10-31 | 1.65M shares 10-Q · filed 2013-12-13 | |||||
| 2013-04-30 | 741.25K shares 10-K · filed 2014-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |